Study Evaluating LXR-623 in Healthy Japanese Adults
NCT00385489
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LXR-623
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer